Previous close | 28.99 |
Open | 31.98 |
Bid | 31.64 x 280000 |
Ask | 32.04 x 190000 |
Day's range | 31.98 - 32.15 |
52-week range | 24.89 - 118.60 |
Volume | |
Avg. volume | 9 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...
SOUTH SAN FRANCISCO, Calif., May 10, 2022--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Steffen Hellmold, senior vice president, business development for data storage, will participate in the 2022 Materials Research Society (MRS) Spring Meeting and Exhibit taking place in Honolulu, Hawai’i May 8-13 and virtually May 23-25. Mr. Hellmold will participate as a
SOUTH SAN FRANCISCO, Calif., May 09, 2022--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has entered into a research collaboration and exclusive option license agreement with Astellas Pharma Inc. Under the terms of the agreement, the companies will jointly conduct research activities to identify and optimize proprietary Twist antagonist antibodies, targeting an